MedTrace Logo

Effect of Nanotechnology Structured Water Magnalife for the Prevention of Recurrent Urinary Tract Infections.

NCT04306731 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 437

Last updated 2020-03-17

No results posted yet for this study

Summary

This study investigates nanotechnology structured water magnalife in urology and to test its effects against lower urinary tract infections (UTI) in females.

Conditions

  • Recurrent Urinary Tract Infection

Interventions

DIETARY_SUPPLEMENT

Nanotechnology Structured water Magnalife

Nanotechnology Structured water Magnalife is drinking water that has been modified using nanotechnology to change the structuring of water molecules

DRUG

Trimethoprim

Antibiotic

DIETARY_SUPPLEMENT

Ordinary bottled drinking water

Placebo

Sponsors & Collaborators

  • University of Sulaimani

    lead OTHER

Principal Investigators

  • Ali K M.Sami, Ph.D. · College of Medicine, University of Sulaimani

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
24 Years
Max Age
80 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-09-20
Primary Completion
2017-04-21
Completion
2017-04-21

Countries

  • Iraq

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04306731 on ClinicalTrials.gov